Taysha Gene Therapies(TSHA) - 2025 Q4 - Earnings Call Transcript

Taysha Gene Therapies (NasdaqGS:TSHA) Q4 2025 Earnings call March 19, 2026 08:30 AM ET Company ParticipantsHayleigh Collins - Senior Director of Corporate Communications and Investor RelationsKamran Alam - CFOSean Nolan - CEOSukumar Nagendran - President and Head of R and DTazeen Ahmad - Managing Director of US Equity ResearchConference Call ParticipantsBiren Amin - Managing Director and Senior Research AnalystChris Raymond - Senior Biotech Research AnalystGil Blum - Senior AnalystJack Allen - AnalystKriste ...